And I think thats another thing, thats really problematic, about the pharmacy benefit managers and this verticalization of health care, which really is moving more towards a monopoly situation
Nature 596 , 583589 (2021)
Q.TrowbridgeI
Therapeutic peptides borrow that same biology and concentrate the effect on a specific system
For more information about how BC Guidelines are developed, refer to the GPAC Handbook available at BCGuidelines.ca: GPAC Handbook
CrossRef Electroacupuncture in the treatment of non-alcoholic fatty liver disease: mechanistic insights and therapeutic potential Yi Wang, Lai Zhang Frontiers in Medicine .2026;[Epub] CrossRef Metabolic DysfunctionAssociated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach Beom Kyung Kim The Kaohsiung Journal of Medical Sciences .2026;[Epub] CrossRef Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Runping Liu, Ranyun Chen, Changmeng Li, Xiaojiaoyang Li MedComm .2026;[Epub] CrossRef Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas Liver Research .2026